Immunome
IMNM
#4888
Rank
A$2.79 B
Marketcap
A$23.70
Share price
-5.54%
Change (1 day)
-17.38%
Change (1 year)

Market capitalization of Immunome (IMNM)

Market cap: A$2.79 Billion

As of November 2026 Immunome has a market cap of A$2.79 Billion. This makes Immunome the world's 4888th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunome from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.79 B-21.74%
2025A$3.57 B238.13%
2024A$1.05 B57.61%
2023A$0.67 B1603.71%
2022A$39.38 M-81.79%
2021A$0.21 B63%
2020A$0.13 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Immunome was reported to be:

A$2.79 Billion
by Nasdaq info icon info icon
A$2.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
A$1.15 B-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA